SCHEMBL4065147

SCHEMBL4065147

CCCCN(C(=O)O)c1ccc(C)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HCAR3 P49019 2/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
OPRM1 P35372 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
S1PR1 P21453 2/20 0.39
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
PAX8 Q06710 2/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 1/20 0.38
JAK2 O60674 1/20 0.38
TP53 P04637 1/20 0.37
GPX4 P36969 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477493 0.79 PKM (0.50) ALDH1A1HCAR3HDAC1HDAC2MEN1
SCHEMBL477491 0.79 PKM (0.50) ALDH1A1HCAR3HDAC1HDAC2MEN1
SCHEMBL5509028 0.78 POLB (0.55) ALDH1A1OPRM1MEN1KMT2AGAA
SCHEMBL12394221 0.77 HCAR3 (0.46) ALDH1A1KDM4EHCAR3HDAC1HDAC2
SCHEMBL13879816 0.74 HCAR3 (0.51) ALDH1A1KDM4EHCAR3HDAC1HDAC2
SCHEMBL11845573 0.74 HCAR3 (0.48) ALDH1A1HCAR3RAB9ANPC1MAPT
SCHEMBL2637165 0.73 RAB9A (0.44) ALDH1A1KDM4EHCAR3HDAC1HDAC2
SCHEMBL11566506 0.73 GBA1 (0.45) HCAR3RAB9ANPC1MAPT
SCHEMBL4244397 0.72 ELANE (0.48) ALDH1A1KDM4EHDAC1HDAC2HDAC6
SCHEMBL11446404 0.71 HTR2C (0.39) ALDH1A1KDM4EHCAR3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049490-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL]-L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS Astra Zeneca AB (SE) 2009-04-22 EP disclosed
WO-2007141473-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS ASTRAZENECA AB (SE) 2007-12-13 WO disclosed